We are proud to inform you that our product BreastIHC is now CE-IVD cleared! This makes Mindpeak the first company to have approval for Deep Learning-driven IHC quantification of the proliferation markers Ki-67, Estrogen and Progesterone in breast tumor that can distinguish tumorous and non-tumorous cells in single-stained IHC slides. BreastIHC is a plug-and-play software that works across most stainers and scanners without parameterization or retraining. This is an enormously important step in our company's short history of only 3 years!

Mindpeak’s CTO Dr. Tobias Lang and Dr. med. Holger Hauspurg describe the future of cancer diagnostics in an article for the magazine Journal Oncology.

"Europe has nearly 4 million new cases of cancer registered every year. Many advances have being made to treat oncology successfully, but the fight is far from over: cancer remains the second leading cause of death globally. This World Cancer Day, on 4th February 2021, is celebrated with the theme “I am, and I will” - a reminder that everyone has the capacity to address the cancer burden. With this motto in mind, we sat down with 3 innovators working on the fight against the disease to discover their achievements and new goals. From AI diagnosis and surgical solutions to new medical devices, new EIC-funded projects are getting closer to treat a disease which previously was called ‘untreatable’. "

Das Hamburger Startup Mindpeak unterstützt Pathologen bei der Krebsdiagnostik: Die mikroskopische Auszählung der Krebszellen erfolgt bei der von Mindpeak entwickelten Anwendung durch Künstliche Intelligenz. Die IFB Hamburg hat das Startup gleich über mehrere Programme gefördert. Darüber hinaus konnte sich Mindpeak die EU-Förderung des EIC Accelerators sichern, die nur wenigen Projekten gewährt wird.

At Mindpeak GmbH we make sure that our A.I. meets the highest standards. As there are sometimes standards missing, we are helping create them!

Künstliche Intelligenz unterstützt Ärzte bei Krebs-DiagnoseDie Zahl der Krebsfälle steigt immer mehr. Eine neue Technologie soll Mediziner dabei unterstützen, die Krankheit zu diagnostizieren.